Tarek A Hammad

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi request reprint Suicide rates in short-term randomized controlled trials of newer antidepressants
    Tarek A Hammad
    Division of Neuropharmocological Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    J Clin Psychopharmacol 26:203-7. 2006
  2. ncbi request reprint Suicidality in pediatric patients treated with antidepressant drugs
    Tarek A Hammad
    Division of Neuropharmacological Drug Products, HFD 120, 5600 Fishers Lane, Rockville, MD 20857, USA
    Arch Gen Psychiatry 63:332-9. 2006
  3. doi request reprint Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink
    Tarek A Hammad
    CDER OSE DEPI I, US Food and Drug Administration, Silver Spring, MD, USA
    Pharmacoepidemiol Drug Saf 22:1233-8. 2013
  4. doi request reprint Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment
    Tarek A Hammad
    Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 30993, USA
    Clin Trials 10:389-97. 2013
  5. doi request reprint Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD
    Andrea V Margulis
    US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 22:942-51. 2013
  6. doi request reprint Atomoxetine use during a period of FDA actions
    Dongyi Tony Du
    Office of Commissioner, US Food and Drug Administration FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Med Care 50:987-92. 2012
  7. pmc Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
    Marc Stone
    Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 0002, USA
    BMJ 339:b2880. 2009
  8. doi request reprint Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008
    Ann W McMahon
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 19:921-33. 2010
  9. ncbi request reprint Predicting nosocomial bloodstream infections using surrogate markers of injury severity: clinical and methodological perspectives
    Maher M El-Masri
    University of Windsor, Faculty of Nursing, Windsor, Ontario, Canada
    Nurs Res 54:273-9. 2005

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Suicide rates in short-term randomized controlled trials of newer antidepressants
    Tarek A Hammad
    Division of Neuropharmocological Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    J Clin Psychopharmacol 26:203-7. 2006
    ....
  2. ncbi request reprint Suicidality in pediatric patients treated with antidepressant drugs
    Tarek A Hammad
    Division of Neuropharmacological Drug Products, HFD 120, 5600 Fishers Lane, Rockville, MD 20857, USA
    Arch Gen Psychiatry 63:332-9. 2006
    ..There has been concern that widely used antidepressant agents might be associated with an increased risk of suicidal ideation and behavior (suicidality) in pediatric patients...
  3. doi request reprint Determining the predictive value of Read codes to identify congenital cardiac malformations in the UK Clinical Practice Research Datalink
    Tarek A Hammad
    CDER OSE DEPI I, US Food and Drug Administration, Silver Spring, MD, USA
    Pharmacoepidemiol Drug Saf 22:1233-8. 2013
    ....
  4. doi request reprint Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment
    Tarek A Hammad
    Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 30993, USA
    Clin Trials 10:389-97. 2013
    ..However, PRISMA may not cover all critical elements useful in the evaluation of meta-analyses with a focus on drug safety particularly in the regulatory-public health setting...
  5. doi request reprint Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD
    Andrea V Margulis
    US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 22:942-51. 2013
    ..We therefore sought to further investigate the association using data from a large population-based cohort in the UK...
  6. doi request reprint Atomoxetine use during a period of FDA actions
    Dongyi Tony Du
    Office of Commissioner, US Food and Drug Administration FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Med Care 50:987-92. 2012
    ..At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005...
  7. pmc Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
    Marc Stone
    Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 0002, USA
    BMJ 339:b2880. 2009
    ..To examine the risk of suicidal behaviour within clinical trials of antidepressants in adults...
  8. doi request reprint Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008
    Ann W McMahon
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 19:921-33. 2010
    ..The investigation identified Baxter Healthcare-brand heparin product due to its strongest association with the events. Later, oversulfated chondroitin sulfate (OSCS), a heparin-like contaminant, was discovered...
  9. ncbi request reprint Predicting nosocomial bloodstream infections using surrogate markers of injury severity: clinical and methodological perspectives
    Maher M El-Masri
    University of Windsor, Faculty of Nursing, Windsor, Ontario, Canada
    Nurs Res 54:273-9. 2005
    ..However, surrogate markers of injury severity (SMIS) may be more clinically meaningful than these commonly used numerical injury severity indices with respect to the control and prevention of nosocomial BSI...